Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Jul 03, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-002090.pdf
Jun 14, 2023	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-23-071187.pdf 0001104659-23-071187.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jun 02, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000072.pdf 0001883850-23-000072.xls
Jun 02, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000073.pdf 0001883850-23-000073.xls
Jun 01, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-001129.pdf
May 18, 2023	PX14A6G	Notice of exempt solicitation. Definitive material	View HTML 0001214659-23-007448.pdf
May 17, 2023	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0001104659-23-061817.pdf 0001104659-23-061817.xls
May 17, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000069.pdf 0001883850-23-000069.xls
May 10, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000013.pdf 0001968202-23-000013.xls
May 04, 2023	8-K	Report of unscheduled material events or corporate event	View HTML 0001804220-23-000015.pdf 0001804220-23-000015.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.

Investors & Media